Skip to main content
SpringerLink
Log in

Inotropika und Vasopressoren

Die Intensivmedizin

Part of the book series: Springer Reference Medizin ((SRM))

  • 795 Accesses

Zusammenfassung

Katecholamine und Vasopressoren gehören zu den in der Intensivmedizin am häufigsten eingesetzten Medikamenten. Sie werden bei hämodynamisch instabilen Patienten verwendet, um durch Erhöhung des Herzzeitvolumens (HZV) und/oder Korrektur des Gefäßtonus akut lebensbedrohliche Situationen abzuwenden. Umso befremdlicher ist es daher, dass sich die Evidenz zu dieser Substanzgruppe im Wesentlichen auf Studien gründet, die lediglich hämodynamische Endpunkte untersucht haben. Untersuchungen zur Auswirkung der verschiedenen Substanzen auf harte Endpunkte wie Morbidität und Letalität fehlen nahezu vollständig. Die Indikationsstellung zur Katecholamintherapie und die Wahl einer bestimmten Substanz müssen sich daher am physiologischen Wirkspektrum, an der sog. „Expertenmeinung“ und an der klinischen Routine des jeweiligen Anwenders orientieren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Bangash MN, Kong ML, Pearse RM (2012) Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol 165:2015–2033

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143

    Article  CAS  PubMed  Google Scholar 

  • Communal C, Singh K, Pimentel DR, Colucci WS (1998) Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98:1329–1334

    Article  CAS  PubMed  Google Scholar 

  • De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–789

    Article  PubMed  Google Scholar 

  • De Backer D, Aldecoa C, Njimi H, Vincent JL (2012) Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med 40:725–730

    Article  PubMed  Google Scholar 

  • Debaveye YA, Van den Berghe GH (2004) Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 98:461–468

    Article  PubMed  Google Scholar 

  • Fellahi JL, Fischer MO, Daccache G, Gerard JL, Hanouz JL (2013) Positive inotropic agents in myocardial ischemia-reperfusion injury: a benefit/risk analysis. Anesthesiology 118:1460–1465

    Article  PubMed  Google Scholar 

  • Grossini E, Caimmi PP, Molinari C, Teodori G, Vacca G (2005) Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig. J Cardiovasc Pharmacol 46:333–342

    Article  CAS  PubMed  Google Scholar 

  • Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden IB (1995) Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27:1859–1866

    Article  CAS  PubMed  Google Scholar 

  • Irlbeck M, Fechner M, Zwissler B (2012) Herz-Kreislauf-wirksame Medikamente. In: Rossaint R, Werner C, Zwissler B (Hrsg) Die Anästhesiologie. Allgemeine und spezielle Anästhesiologie, Schmerztherapie und Intensivmedizin. 3. Aufl. Springer, Berlin/Heidelberg/New York, S S 331–S 351

    Google Scholar 

  • Kivikko M, Antila S, Eha J, Lehtonen L, Pentikainen PJ (2002) Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure. Int J Clin Pharmacol Ther 40:465–471

    Article  CAS  PubMed  Google Scholar 

  • Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595

    Article  CAS  PubMed  Google Scholar 

  • Lawson NW, Johnson JO (2001) Autonomic nervous system: physiology and pharmacology. In: Barash PG, Cullen BF, Stoelting RK (Hrsg) Clinical anesthesia. 4. Aufl. Lippincott Williams & Wilkins, Philadelphia, S 261–325

    Google Scholar 

  • Levy B (2005) Bench-to-bedside review: is there a place for epinephrine in septic shock? Crit Care 9:561–565

    Article  PubMed Central  PubMed  Google Scholar 

  • Li HT, Long CS, Rokosh DG, Honbo NY, Karliner JS (1995) Chronic hypoxia differentially regulates alpha 1-adrenergic receptor subtype mRNAs and inhibits alpha 1-adrenergic receptor-stimulated cardiac hypertrophy and signaling. Circulation 92:918–925

    Article  CAS  PubMed  Google Scholar 

  • Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenpera M (1998) Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19:660–668

    Article  CAS  PubMed  Google Scholar 

  • Modest VE, Butterworth JF (1995) Effect of pH and lidocaine on beta-adrenergic receptor binding. Interaction during resuscitation? Chest 108:1373–1379

    Article  CAS  PubMed  Google Scholar 

  • Overgaard CB, Dzavik V (2008) Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 118:1047–1056

    Article  PubMed  Google Scholar 

  • Persichini R, Silva S, Teboul JL, Jozwiak M, Chemla D, Richard C, Monnet X (2012) Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med 40:3146–3153

    Article  CAS  PubMed  Google Scholar 

  • Pollesello P, Mebazaa A (2004) ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care 10:436–441

    Article  PubMed  Google Scholar 

  • Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS (2001) Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189:257–265

    Article  CAS  PubMed  Google Scholar 

  • Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ, Michler RE, Koller A, Hintze TH, Kaley G (2002) Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 106:550–555

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Campus Gasthuisberg & Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Herestraat 49, 3000, Leuven, Belgien

    Steffen Rex

Authors
  1. Steffen Rex
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steffen Rex .

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, RWTH Aachen Universitätsklinikum Aachen, Aachen, Germany

    Gernot Marx

  2. Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck, Germany

    Elke Muhl

  3. Dir. der Klinik fuer Anaesthesie Intensivmed. und Schmerzther., Frankfurt, Hessen, Germany

    Kai Zacharowski

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Berlin Heidelberg

About this entry

Cite this entry

Rex, S. (2015). Inotropika und Vasopressoren. In: Marx, G., Muhl, E., Zacharowski, K. (eds) Die Intensivmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54675-4_40-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54675-4_40-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-54675-4

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Inotropika und Vasopressoren
    Published:
    21 September 2023

    DOI: https://doi.org/10.1007/978-3-642-54675-4_40-2

  2. Original

    Inotropika und Vasopressoren
    Published:
    30 March 2015

    DOI: https://doi.org/10.1007/978-3-642-54675-4_40-1

Search

Navigation